Kelly Lawrence W & Associates’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $269K | Hold |
|
|||||
|
2025
Q1 | $293K | Hold |
|
|||||
|
2024
Q4 | $244K | Hold |
|
|||||
|
2024
Q3 | $281K | Sell |
|
|||||
|
2024
Q2 | $612K | Sell |
|
|||||
|
2024
Q1 | $609K | Sell |
|
|||||
|
2023
Q4 | $597K | Hold |
|
|||||
|
2023
Q3 | $510K | Hold |
|
|||||
|
2023
Q2 | $503K | Hold |
|
|||||
|
2023
Q1 | $463K | Sell |
|
|||||
|
2022
Q4 | $464K | Sell |
|
|||||
|
2022
Q3 | $610K | Hold |
|
|||||
|
2022
Q2 | $594K | Hold |
|
|||||
|
2022
Q1 | $550K | Sell |
|
|||||
|
2021
Q4 | $468K | Hold |
|
|||||
|
2021
Q3 | $386K | Hold |
|
|||||
|
2021
Q2 | $429K | Hold |
|
|||||
|
2021
Q1 | $457K | Buy |
|
|||||
|
2020
Q4 | $186K | Sell |
|
|||||
|
2020
Q3 | $695K | Buy |
|
|||||
|
2020
Q2 | $735K | Sell |
|
|||||
|
2020
Q1 | $1.84M | Sell |
|
|||||
|
2019
Q4 | $1.81M | Sell |
|
|||||
|
2019
Q3 | $1.5M | Sell |
|
|||||
|
2019
Q2 | $1.66M | Sell |
|
|||||
|
2019
Q1 | $1.8M | Sell |
|
|||||
|
2018
Q4 | $1.86M | Sell |
|
|||||
|
2018
Q3 | $2.18M | Sell |
|
|||||
|
2018
Q2 | $2.01M | Sell |
|
|||||
|
2018
Q1 | $2.17M | Sell |
|
|||||
|
2017
Q4 | $3.04M | Sell |
|
|||||
|
2017
Q3 | $3.15M | Sell |
|
|||||
|
2017
Q2 | $2.72M | Hold |
|
|||||
|
2017
Q1 | $2.31M | Buy |
|
|||||
|
2016
Q4 | $1.55M | Sell |
|
|||||
|
2016
Q3 | $8.56M | Sell |
|
|||||
|
2016
Q2 | $8.45M | Buy |
|